Global Chondroitin Sulfate Market is valued at approximately USD 1.21 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.5% over the forecast period 2022-2029. Chondroitin sulfate is also named glycosaminoglycan sulfated glucose (GAG). Chondroitin sulfate is composed of a long chain of alternating sugars such as glucuronic acid and N-acetylga-lactosamine. This molecule is an important part of the extracellular matrix, which is formed of several connective tissues like bone, cartilage, tendons, and ligaments. Commercial production of chondroitin sulfate uses a variety of animal sources, including pigs, chickens, cows, fish, sharks, crocodiles, and other creatures. The rising demand for nutraceutical goods, coupled with the growing demand in animal feed industry are acting as catalyzing factors for the demand for chondroitin sulfate in the global market.
The rising incidencfes of osteoarthritis is playing a ignificant role for propelling the market demand across the globe. The World Health Organization Association (WHO), stated that globally around9.6% of men and 18% of women aged more than 60 are suffering from symptomatic osteoarthritis. Among these, nearly 80% have problems in movement and 25% are not able to perform day-to-day activities. Thereby, the rising incidence rate of orthopedic disorders is likely to stipulate the growth of global plasma therapy market. Thereby, the rising usage of chondroitin sulfate for the treatment of osteoarthritis is augmenting the market expansion at a significant rate. Moreover, rising investment in research and development, as well as the growing applications of chondroitin sulfate are presenting various lucrative opportunities over the forecasting years. However, adverse effects of chondroitin sulfate and stringent regulations by various regulatory bodies are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Chondroitin Sulfate Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of osteoarthritis, along with the increasing United States Food and Drug Administration approvals for chondroitin sulfate. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the growing aging population in emerging nations, as well as rising use of sodium chondroitin sulfate-infused pharmaceuticals and nutraceuticals in the market space.
Major market players included in this report are:
- TSI Group Ltd.
- Qingdao Wan Toulmin Biological Sources Co., Ltd.
- Hebei SanXin Industrial Group
- Bioiberica SAU
- Sigma Aldrich, Inc.
- ZPD
- Sino Siam Biotechnique Company Ltd.
- BRF
- Bio-gen Extracts Pvt. Ltd.
- Seikagaku Corp.
Recent Developments in the Market:
- In July 2022, Infinitus unveiled the introduction of a new series of Li Mai Jian supplements with the theme 'Making Bones Stronger for Joint Health'.
- In March 2022, Bioiberica, a global life science company announced that the company entered into a partnership agreement with ByHealth, The key objective of this partnership is to introduce a new product for its market-leading joint health brand, Highflex. Highflex type II collagen tablets is developed to fulfill the unmet requirements of consumer for innovative, low-dose joint health solutions across China.
Global Chondroitin Sulfate Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Source, Application, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Source:
- Bovine
- Swine
- Poultry
- Shark
- Synthetic
By Application:
- Nutraceuticals
- Pharmaceuticals
- Animal Feed
- Personal Care & Cosmetics
- Other Applications
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Chondroitin Sulfate Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Chondroitin Sulfate Market, by Source, 2019-2029 (USD Billion)
- 1.2.3. Chondroitin Sulfate Market, by Application, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Chondroitin Sulfate Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Chondroitin Sulfate Market Dynamics
- 3.1. Chondroitin Sulfate Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising demand for nutraceutical goods
- 3.1.1.2. Increasing prevalence of osteoarthritis
- 3.1.2. Market Challenges
- 3.1.2.1. Adverse effects of chondroitin sulfate
- 3.1.2.2. Stringent regulations by various regulatory bodies
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising investment in research and development
- 3.1.3.2. Growing applications of chondroitin sulfate
Chapter 4. Global Chondroitin Sulfate Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Chondroitin Sulfate Market, by Source
- 6.1. Market Snapshot
- 6.2. Global Chondroitin Sulfate Market by Source, Performance - Potential Analysis
- 6.3. Global Chondroitin Sulfate Market Estimates & Forecasts by Source 2019-2029 (USD Billion)
- 6.4. Chondroitin Sulfate Market, Sub Segment Analysis
- 6.4.1. Bovine
- 6.4.2. Swine
- 6.4.3. Poultry
- 6.4.4. Shark
- 6.4.5. Synthetic
Chapter 7. Global Chondroitin Sulfate Market, by Application
- 7.1. Market Snapshot
- 7.2. Global Chondroitin Sulfate Market by Application, Performance - Potential Analysis
- 7.3. Global Chondroitin Sulfate Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
- 7.4. Chondroitin Sulfate Market, Sub Segment Analysis
- 7.4.1. Nutraceuticals
- 7.4.2. Pharmaceuticals
- 7.4.3. Animal Feed
- 7.4.4. Personal Care & Cosmetics
- 7.4.5. Other Applications
Chapter 8. Global Chondroitin Sulfate Market, Regional Analysis
- 8.1. Chondroitin Sulfate Market, Regional Market Snapshot
- 8.2. North America Chondroitin Sulfate Market
- 8.2.1. U.S. Chondroitin Sulfate Market
- 8.2.1.1. Source breakdown estimates & forecasts, 2019-2029
- 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Chondroitin Sulfate Market
- 8.3. Europe Chondroitin Sulfate Market Snapshot
- 8.3.1. U.K. Chondroitin Sulfate Market
- 8.3.2. Germany Chondroitin Sulfate Market
- 8.3.3. France Chondroitin Sulfate Market
- 8.3.4. Spain Chondroitin Sulfate Market
- 8.3.5. Italy Chondroitin Sulfate Market
- 8.3.6. Rest of Europe Chondroitin Sulfate Market
- 8.4. Asia-Pacific Chondroitin Sulfate Market Snapshot
- 8.4.1. China Chondroitin Sulfate Market
- 8.4.2. India Chondroitin Sulfate Market
- 8.4.3. Japan Chondroitin Sulfate Market
- 8.4.4. Australia Chondroitin Sulfate Market
- 8.4.5. South Korea Chondroitin Sulfate Market
- 8.4.6. Rest of Asia Pacific Chondroitin Sulfate Market
- 8.5. Latin America Chondroitin Sulfate Market Snapshot
- 8.5.1. Brazil Chondroitin Sulfate Market
- 8.5.2. Mexico Chondroitin Sulfate Market
- 8.5.3. Rest of Latin America Chondroitin Sulfate Market
- 8.6. Rest of The World Chondroitin Sulfate Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. TSI Group Ltd.
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Qingdao Wan Toulmin Biological Sources Co., Ltd.
- 9.2.3. Hebei SanXin Industrial Group
- 9.2.4. Bioiberica SAU
- 9.2.5. Sigma Aldrich, Inc.
- 9.2.6. ZPD
- 9.2.7. Sino Siam Biotechnique Company Ltd.
- 9.2.8. BRF
- 9.2.9. Bio-gen Extracts Pvt. Ltd.
- 9.2.10. Seikagaku Corp.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption